Warrasak, Sukhuma
Euswas, Ataya
Fukuda, Mark M.
Ittiverakul, Mali
Miller, R. Scott
Krudsood, Srivicha
Ohrt, Colin
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (RC1AI048874-01, UC1AI049499-01)
US Army Medical Research and Material Command
GlaxoSmithKline
Article History
Received: 16 April 2018
Accepted: 11 August 2018
First Online: 29 September 2018
Compliance with ethical standards
:
: The authors have no proprietary or commercial interest in any materials discussed in this article.
: This study was conducted in accordance with Good Clinical Practice and the guiding principles of the Declaration of Helsinki. The protocol was approved by the Ethical Committee, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand, the Ministry of Public Health, Nonthaburi, Thailand, and the Human Subjects Research Review Board, U.S. Army Medical Research and Material Command, Office of Regulatory Compliance and Quality, Fort Detrick, MD, USA. All participants provided written informed consent before entry into the study. The protocol can be obtained from the corresponding authors. The trial is registered at Clinicaltrials.gov identifier: NCT01290601.